WebJun 17, 2014 · Glycomimetics, Inc. 19 Follow Quote Board Chart Level 2 News Trades Options New Financials Historical New Post About Popular Latest Posts Older willlbone 02/15/23 3:28 PM Dilution. INFINITI... WebFeb 16, 2024 · GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on February 10, 2024 of a non-qualified stock option award to purchase an aggregate of 150,000 shares to Chinmaya Rath, the Company’s new Senior Vice President and Chief …
News - FOX 5 Atlanta
WebFind the latest GlycoMimetics, Inc. (GLYC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. WebJune 13 2016 - 09:00AM. Business Wire. GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its novel E-selectin antagonist GMI-1271 for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) and elderly patients … how to take screenshot in oppo
GlycoMimetics (GLYC) Stock News Today - TipRanks.com
WebApr 11, 2024 · In other news, CEO Bruce C. Cozadd sold 1,000 shares of the business’s stock in a transaction dated Wednesday, February 1st. The shares were sold at an average price of $155.79, for a total ... WebApr 5, 2024 · 1 brokerages have issued 1-year price targets for GlycoMimetics' shares. Their GLYC share price forecasts range from $8.00 to $8.00. On average, they anticipate the … WebGLYC Stock Summary. With a price/sales ratio of 786.71, GLYCOMIMETICS INC has a higher such ratio than 99.42% of stocks in our set. As for revenue growth, note that … reagan arms for contras